Table 3.
Cancer mortality and incidence for select ICD-9 groups
| Cancer Mortality | Cancer Incidence | |||||||
|---|---|---|---|---|---|---|---|---|
| (ICD) Cancer Subtype | Obs | Exp | SMR | 95%CI | Obs | Exp | SIR | 95%CI |
| (140) Malignant neoplasm of lip | 0 | - | - | - | 6 | 8.6 | 0.70 | 0.14 -1.26 |
| (141) Malignant neoplasm of tongue | 9 | 6.4 | 1.41 | 0.48 - 2.33 | 12 | 7.6 | 1.58 | 0.68 - 2.48 |
| (146) Malignant neoplasm of oropharynx | 3 | 4.5 | 0.66 | 0.00 - 1.41 | 6 | 7.7 | 0.78 | 0.15 - 1.40 |
| (140 - 149) Lip, Oral Cavity, and Pharynx | 25 | 21.8 | 1.14 | 0.75 - 1.65 | 41 | 42.1 | 0.98 | 0.71 - 1.31 |
| (150) Malignant neoplasm of esophagus | 23 | 15.0 | 1.53 | 0.90 - 2.16 | 19 | 14.0 | 1.36 | 0.74 - 1.97 |
| (151) Malignant neoplasm of stomach | 102 | 80.6 | 1.27 | 1.02 - 1.51 | 108 | 78.9 | 1.37 | 1.11 - 1.63 |
| (152) Malignant neoplasm of small intestine, including duodenum | 6 | 2.1 | 2.91 | 0.57 - 5.25 | 7 | 2.1 | 3.26 | 0.83 - 5.69 |
| (153) Malignant neoplasm colon | 54 | 59.7 | 0.90 | 0.66 - 1.15 | 80 | 75.7 | 1.06 | 0.82 - 1.29 |
| (154) Malignant neoplasm of rectum, rectosigmoid junction, and anus | 80 | 60.2 | 1.33 | 1.04 - 1.62 | 119 | 84.4 | 1.41 | 1.16 - 1.66 |
| (155) Malignant neoplasm of liver and intrahepatic bile ducts | 48 | 29.4 | 1.63 | 1.17 - 2.10 | 38 | 22.3 | 1.70 | 1.16 - 2.25 |
| (156) Malignant neoplasm of gallbladder and extrahepatic bile ducts | 13 | 14.7 | 0.88 | 0.40 - 1.37 | 9 | 14.8 | 0.61 | 0.21 - 1.00 |
| (157) Malignant neoplasm of pancreas | 53 | 44.6 | 1.19 | 0.87 - 1.51 | 54 | 41.3 | 1.31 | 0.96 - 1.66 |
| (159) Malignant neoplasm of other and ill-defined sites | 14 | 7.7 | 1.82 | 0.86 - 2.77 | 16 | 4.9 | 3.29 | 1.67 - 4.91 |
| (140-148, 160, 161) Extrathoracic airway* | 59 | 41.8 | 1.41 | 1.15 - 1.77 | 80 | 68.9 | 1.16 | 0.95 - 1.39 |
| (150 - 159) Digestive organs and peritoneum | 396 | 316.7 | 1.25 | 1.13 - 1.38 | 453 | 340.8 | 1.33 | 1.21 - 1.46 |
| (161) Malignant neoplasm of larynx | 33 | 19.8 | 1.67 | 1.10 - 2.24 | 45 | 33.6 | 1.34 | 0.95 - 1.73 |
| (162) Malignant neoplasm of trachea, bronchus, and lung | 705 | 332.3 | 2.12 | 1.96 - 2.28 | 755 | 326.2 | 2.31 | 2.15 - 2.48 |
| (163) Malignant neoplasm of pleura | 5 | 2.4 | 2.06 | 0.25 - 3.87 | 5 | 2.5 | 1.97 | 0.24 - 3.71 |
| (160 - 165) Respiratory and Intrathoracic | 749 | 358.5 | 2.09 | 1.95 - 2.25 | 808 | 367.0 | 2.20 | 2.05 - 2.36 |
| (171) Malignant neoplasm of connective and other soft tissue | 3 | 2.8 | 1.07 | 0.00 - 2.28 | 5 | 6.9 | 0.72 | 0.09 - 1.36 |
| (172) Malignant melanoma of skin | 14 | 11.9 | 1.18 | 0.56 - 1.80 | 18 | 23.3 | 0.77 | 0.41 - 1.13 |
| (173) Other malignant neoplasm of skin | 1 | 2.6 | 0.39 | 0.00 - 1.16 | 129 | 190.3 | 0.68 | 0.56 - 0.80 |
| ICD 170 - 175: Bone, Connective tissue, Skin, and Breast | 22 | 21.8 | 1.00 | 0.64 - 1.49 | 157 | 224.9 | 0.70 | 0.59 - 0.81 |
| (185) Malignant neoplasm of prostate | 30 | 45.1 | 0.67 | 0.43 - 0.90 | 57 | 65.9 | 0.86 | 0.64 - 1.09 |
| (186) Malignant neoplasm of testis | 4 | 3.8 | 1.05 | 0.02 - 2.09 | 10 | 11.7 | 0.85 | 0.32 - 1.38 |
| (187) Malignant neoplasm of penis and other male genital organs | 4 | 1.4 | 2.81 | 0.04 - 5.57 | 6 | 3.4 | 1.76 | 0.35 - 3.18 |
| (188) Malignant neoplasm of bladder | 29 | 27.7 | 1.05 | 0.67 - 1.43 | 54 | 50.8 | 1.06 | 0.78 - 1.35 |
| (189) Malignant neoplasm of kidney and other and unspecified urinary organs | 41 | 40.9 | 1.00 | 0.69 - 1.31 | 49 | 55.9 | 0.88 | 0.63 - 1.12 |
| ICD 185 - 189: Genitourinary Organs | 108 | 118.9 | 0.91 | 0.75 - 1.09 | 176 | 187.8 | 0.94 | 0.81 - 1.08 |
| (191) Malignant neoplasm of brain | 13 | 17.0 | 0.76 | 0.35 - 1.18 | 13 | 15.6 | 0.83 | 0.38 - 1.29 |
| (193) Malignant neoplasm of thyroid gland | 2 | 2.2 | 0.91 | 0.00 - 2.19 | 5 | 4.3 | 1.17 | 0.14 - 2.20 |
| (195) Malignant neoplasm of other and ill-defined sites | 5 | 4.3 | 1.17 | 0.14 - 2.19 | 3 | 3.4 | 0.87 | 0.00 - 1.86 |
| (197) Secondary malignant neoplasm of respiratory and digestive systems | 8 | 0.1 | 71.70 | 21.81 - 121.60 | 7 | 5.4 | 1.29 | 0.33 - 2.25 |
| (198) Secondary malignant neoplasm of other specified sites | 6 | 0.1 | 52.86 | 10.39 - 95.33 | 13 | 4.5 | 2.86 | 1.30 - 4.42 |
| (199) Malignant neoplasm without specification of site | 14 | 13.8 | 1.02 | 0.48 - 1.55 | 19 | 8.0 | 2.36 | 1.30 - 3.43 |
| (190 - 199) Other and unspecified sites | 53 | 39.2 | 1.36 | 1.03 - 1.76 | 68 | 49.1 | 1.38 | 1.09 - 1.75 |
| (200) Lymphosarcoma and reticulosarcoma | 7 | 4.5 | 1.57 | 0.40 - 2.73 | 7 | 7.4 | 0.94 | 0.24 - 1.64 |
| (201) Hodgkin’s disease | 8 | 6.8 | 1.18 | 0.36 - 2.00 | 15 | 9.5 | 1.57 | 0.77 - 2.37 |
| (202) Other malignant neoplasms of lymphoid and histiocytic tissue | 10 | 10.2 | 0.98 | 0.37 - 1.58 | 10 | 14.1 | 0.71 | 0.27 - 1.15 |
| (203) Multiple myeloma and immunoproliferative neoplasms | 8 | 7.5 | 1.07 | 0.33 - 1.82 | 16 | 9.2 | 1.75 | 0.89 - 2.61 |
| (204) Lymphoid leukemia | 11 | 10.6 | 1.03 | 0.42 - 1.65 | 21 | 13.3 | 1.57 | 0.90 - 2.25 |
| (205) Myeloid leukemia | 12 | 8.8 | 1.36 | 0.59 - 2.14 | 14 | 8.8 | 1.58 | 0.75 - 2.42 |
| (204-208) All Leukemia^ | 25 | 24.0 | 1.05 | 0.69 - 1.52 | 37 | 24.0 | 1.51 | 1.08 - 2.07 |
| (200 - 208) Lymphatic and Hematopoietic | 58 | 52.8 | 1.09 | 0.84 - 1.41 | 85 | 64.7 | 1.31 | 1.05 - 1.61 |
| (140 - 232) All cancer types | 1411 | 929.6 | 1.52 | 1.44 - 1.60 | 1788 | 1276.5 | 1.40 | 1.34 - 1.47 |
*
Extrathoracic airway includes cancers of the oral cavity and pharynx (141 - 148), nasal cavities (160) and larynx (161)
^
Lymphoid, Myeloid, other and unspecified leukemia
Obs = Observed, Exp = Expected, SMR/SIR = Standardized Mortality/Incidence Ratio, CI = Confidence Interval